Home » Topics » Regulatory

Regulatory
RSS

Teveten HCT receives marketing approval in U.S.

Dec. 4, 2001

FDA clears injectable antibiotic Invanz

Dec. 3, 2001

FDA marketing approval granted for improved form of Ritalin for ADHD

Dec. 3, 2001

Canadian approval for Fludara as NHL treatment

Dec. 3, 2001

Zenapax enters phase II trial in patients with chronic asthma

Dec. 3, 2001

Basiliximab: use in GI inflammatory disorders

Nov. 29, 2001

FDA approves expanded use of Myoview

Nov. 28, 2001

European Commission extends pramipexole's indications to include initial monotherapy

Nov. 28, 2001

Sheffield initiates budesonide inhalation suspension study

Nov. 27, 2001

Pharmaceutical compositions of rFVIIa designed at Novo Nordisk

Nov. 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...